CJClara Lirian Javarini

Clara Lirian Javarini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Clara Lirian Javarini has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • State-of-Art on the Synthesis of Heterocyclic Compounds Targeting SARS-CoV-2

    by Pedro Alves Bezerra Morais, Jessica Adalgisa Barbosa Silva, Clara Lirian Javarini, Caroline de Souza Fontes Gaspari, Ramon Ramires Trancoso Bottocim, Thays Cardoso Valim, Carla Santana Francisco, Alvaro Cunha Neto, Valdemar Lacerda Junior

    The Corona virus disease-19 (COVID-19) pandemic challenged the scientific community in the search for developing effective treatments, such as medicine and/or a vaccine candidate. The SARS-CoV-2 virus and its variants, Omega, Omicron, and Delta, remain as a major threat to human health, causing significant morbidity and mortality worldwide. Given that computational methods are thought to be quick, easy, and inexpensive, they have been widely used in this scenario to design new anti-COVID-19 drug candidates. In addition, heterocyclic scaffolds have been explored exhaustively for their biological properties and as fruitful sources of new molecular entities to fulfill the chemical space available.In light of this, we intend to highlight the synthetic techniques used to produce novel heterocyclic derivatives that may serve as effective anti-COVID-19 lead candidates by focusing on important viral proteins and using computational tools. Then, the objective of this article, with a theoretical nature, is to contribute to the delimitation of organic chemistry methods to achieve new anti- COVID-19 agents.


  • Triazole: A New Perspective in Medicinal Chemistry and Material Science

    by Pedro Alves Bezerra Morais, Clara Lirian Javarini, Thays Cardoso Valim, Carla Santana Francisco, Lara Chaves de Freitas Ferreira, Ramon Ramires Trancoso Bottocim, Álvaro Cunha Neto, Valdemar Lacerda Júnior

    Triazole, which can exist in two isomeric forms: 1,2,3- and 1,2,4-triazole, is considered to be a privileged scaffold with recognized biological and pharmaceutical potential. Furthermore, due to their physicochemical properties, the applications of triazoles have been explored in fields ranging from medicinal chemistry to materials science. Triazoles have not only drawn the attention of the scientific community for all the aforementioned properties but also due to their ability to be incorporated into other bioactive and functional molecules. The connection between two pharmacophores makes it possible to potentiate specific biological activities or add different properties. Interest in the compatibility of the triazole nucleus with peptide structures is highlighted in the development of new therapeutic targets. In epigenetics, triazole is linked to various compounds that are used in the creation of new drugs that could potentially inhibit histone-modifying enzymes. Other new and potentially more effective materials that can take advantage of a triazole moiety include light-emitting diodes and solar cells, among others. Hence, we propose a novel approach to the promising applications of triazolic ring, a compound that has been gaining prominence in organic chemistry due to its applicability to many different fields.